Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Ophthalmology (Rochester, Minn.)

• Publication date

  2012-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ophtha.2011.09.040PMID 22137042
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Histopathologic observations after intra-arterial chemotherapy for retinoblastoma.

  2011cited by this paper
• Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications.

  2011cited by this paper
• Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.

  2011cited by this paper
• Histopathologic Findings of Eyes Enucleated After Treatment with Chemosurgery for Retinoblastoma

  2011cited by this paper
• Isolated limb perfusion for unresectable extremity sarcoma

  2011cited by this paper
• OCCURRENCE OF SECTORAL CHOROIDAL OCCLUSIVE VASCULOPATHY AND RETINAL ARTERIOLAR EMBOLIZATION AFTER SUPERSELECTIVE OPHTHALMIC ARTERY CHEMOTHERAPY FOR ADVANCED INTRAOCULAR RETINOBLASTOMA

  2011cited by this paper
• Intra‐arterial chemotherapy for retinoblastoma: the beginning of a long journey

  2010cited by this paper
• Super selective ophthalmic artery delivery of chemotherapy for intraocular retinoblastoma: ‘chemosurgery’The first Stallard lecture

  2010cited by this paper
• Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy.

  2010cited by this paper
• Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy

  2010cited by this paper
• Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).

  2010cited by this paper
• Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma

  2009cited by this paper
• A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.

  2009cited by this paper
• Superselective catheterization of the ophthalmic artery for intraarterial chemotherapy for retinoblastoma.

  2009cited by this paper
• Cavitary retinoblastoma: ultrasonographic and fluorescein angiographic findings in 3 cases.

  2008cited by this paper
• A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.

  2008cited by this paper
• Retinoblastoma: what is new in 2007–2008

  2008cited by this paper
• Osmotic blood–brain barrier disruption chemotherapy for diffuse pontine gliomas

  2006cited by this paper
• Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood‐brain‐barrier disruption

  2006cited by this paper
• The International Classification of Retinoblastoma predicts chemoreduction success.

  2006cited by this paper
• The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma

  2004cited by this paper
• Management of intraocular retinoblastoma and ocular prognosis

  2004cited by this paper
• Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.

  2004cited by this paper
• A new era for the treatment of retinoblastoma.

  1996cited by this paper
• Occult retinal and choroidal vascular disease. The value of timed and directed fluorescein angiography.

  1994cited by this paper
• Occult Retinal and Choroidal Vascular Disease: The Value of Timed and Directed Fluorescein Angiography

  1993cited by this paper
• A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma.

  1992cited by this paper
• Visual toxicity following intra-arterial chemotherapy with hydroxyethyl-CNU in patients with malignant gliomas

  1991cited by this paper
• Intraarterial infusion of carboplatin in the treatment of malignant gliomas: a phase II study.

  1989cited by this paper
• Color photography vs fluorescein angiography in the detection of diabetic retinopathy in the diabetes control and complications trial

  1987cited by this paper
• Chemosensitivity profiles of primary and cultured human retinoblastoma cells in a human tumor clonogenic assay.

  1987cited by this paper
• Color photography vs fluorescein angiography in the detection of diabetic retinopathy in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.

  1987cited by this paper
• Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis.

  1986cited by this paper
• Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system.

  1984cited by this paper
• FLUORESCEIN ANGIOGRAPHY OF RETINOBLASTOMA

  1982cited by this paper
• Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions.

  1982cited by this paper
• Application of fluorescein angiography in retinoblastoma.

  1982cited by this paper
• Fluorescein angiography in retinoblastoma.

  1982cited by this paper
• Intra-arterial BCNU chemotherapy for the treatment of malignant gliomas of the central nervous system: a preliminary report.

  1981cited by this paper
• Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer.

  1981cited by this paper
• An Aid in the Differential Diagnosis of Intraocular Tumors

  1972cited by this paper
• [Retrograde infusion of anti-cancer drugs to ophthalmic artery for intraocular malignant tumors].

  1966cited by this paper
• The treatment of retinoblastoma by x-ray and triethylene melamine.

  1958cited by this paper

• Microrobotic Catheterization of the Ophthalmic Artery for Targeted Treatment of Retinoblastoma

  2026cites this paper
• Choroidal Neovascularization following Intra-Arterial Melphalan Chemotherapy for Retinoblastoma

  2025cites this paper
• Intraocular Surgery for Retinoblastoma: An Evaluation of Current Evidence

  2024cites this paper
• Recent Advances in Interventional Fluorescence Imaging: Toward the Precise Visualization of Transarterial Mini-Invasive Delivery Systems

  2023cites this paper
• Dysfunctional Autophagy, Proteostasis, and Mitochondria as a Prelude to Age-Related Macular Degeneration

  2023cites this paper
• Angiographic characteristics and treatment approach in patients undergoing intra-arterial chemotherapy for retinoblastoma

  2023cites this paper
• Follow-up of retinoblastoma using RetCam fluorescein angiography and correlation with clinical findings

  2023cites this paper
• Retinoblastoma: Recent Trends in Diagnosis and Management

  2022cites this paper
• Choroidal occlusive vasculopathy after intraarterial chemotherapy: MRI findings.

  2022cites this paper
• Vasculopatía coroidea oclusiva tras quimioterapia intraarterial: hallazgos en la RMN

  2022cites this paper
• Intra-Arterial Chemotherapy as Primary Treatment for Advanced Unilateral Retinoblastoma in China

  2022cites this paper
• Retinoblastoma and vision

  2022cites this paper
• Intraarterial Chemotherapy for Retinoblastoma – Initial Experiences of a German Reference Centre Intraarterielle Chemotherapie beim Retinoblastom – erste Erfahrungen eines deutschen Referenzzentrums

  2021cites this paper
• Retinoblastoma: What the Neuroradiologist Needs to Know

  2021cites this paper
• Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma

  2021cites this paper
• Optical Coherence Tomography Angiography Microvascular Variations in Pre- and Posttreatment of Retinoblastoma Tumors

  2021cites this paper
• New approach of chemotherapy for the treatment of retinoblastoma: a review

  2020cites this paper
• Superselective intra-arterial chemotherapy treatment for retinoblastoma: clinical experience from a tertiary referral centre.

  2020cites this paper
• [Retinoblastoma].

  2020cites this paper
• Combined intra-arterial chemotherapy and intravitreal melphalan for the treatment of advanced unilateral retinoblastoma.

  2020cites this paper
• Iatrogenic Ophthalmic Artery Occlusion and Retinal Artery Occlusion.

  2020cites this paper
• Retinoblastom

  2020cites this paper
• Strategies for Improved Intra-arterial Treatments Targeting Brain Tumors: a Systematic Review

  2020cites this paper
• Pathologic comparisons of enucleated eyes with retinoblastoma after superselective ophthalmic arterial chemotherapy with or without intravenous chemotherapy.

  2020cites this paper
• Intraocular Tumors: Angiographic Patterns

  2020cites this paper
• Risk factors for acute choroidal ischemia after intra-arterial melphalan for retinoblastoma: the role of the catheterization approach.

  2020cites this paper
• miR-4516 inhibits the apoptosis of RB tumor cells by targeting the PTEN/AKT signaling pathway.

  2020cites this paper
• Microvascular Features of Treated Retinoblastoma Tumors in Children Assessed Using OCTA.

  2019cites this paper
• INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THE MANAGEMENT OF NEOVASCULARIZATION IN RETINOBLASTOMA AFTER INTRAVENOUS AND/OR INTRAARTERIAL CHEMOTHERAPY: Long-Term Outcomes in a Series of 35 Eyes.

  2019cites this paper
• Rabbit Model of Intra-Arterial Chemotherapy Toxicity Demonstrates Retinopathy and Vasculopathy Related to Drug and Dose, Not Procedure or Approach

  2019cites this paper
• Diagnostic Techniques: Angiography

  2019cites this paper
• Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. "Alive, with good vision and no comorbidity".

  2019cites this paper
• Retinoblastoma vascular perfusion and intra‐arterial chemotherapy cycle requirements

  2019cites this paper
• Histopathology of retinoblastoma eyes enucleated after intra-arterial chemotherapy

  2019cites this paper
• Fluorescein angiography findings in both eyes of a unilateral retinoblastoma case during intra-arterial chemotherapy with melphalan.

  2019cites this paper
• MACULOPATHY AND CHORIORETINOPATHY IN CHILDREN WITH RETINOBLASTOMA RECEIVING CHEMOTHERAPY: CLINICAL TRIALS AND MORPHOMETRIC ANALYSIS

  2018cites this paper
• Ophthalmic Vascular Events after Primary Unilateral Intra-arterial Chemotherapy for Retinoblastoma in Early and Recent Eras.

  2018cites this paper
• Choroidal Ischemia Sparing the Watershed Zone following Intra-Arterial Chemotherapy for Retinoblastoma

  2018cites this paper
• The radioprotector ortho-phospho-L-tyrosine (pTyr) attenuates the side effects of fractionated irradiation in retinoblastoma mouse models but also decreases the local tumour control.

  2017cites this paper
• RHEGMATOGENOUS RETINAL DETACHMENT AFTER INTRAARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: The 2016 Founders Award Lecture

  2017cites this paper
• Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma.

  2016cites this paper
• Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes.

  2016cites this paper
• Endovascular Management of Tumors of the Head, Neck, and Spine

  2015cites this paper
• Retinoblastoma: Achieving new standards with methods of chemotherapy

  2015cites this paper
• Current and emerging therapy for improving outcomes in patients with intraocular retinoblastoma

  2015cites this paper
• Complications of Intra-Arterial Chemotherapy for Retinoblastoma

  2014cites this paper
• Electroretinogram Monitoring of Dose-Dependent Toxicity after Ophthalmic Artery Chemosurgery in Retinoblastoma Eyes: Six Year Review

  2014cites this paper
• The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation.

  2014cites this paper
• Retcam fluorescein angiography findings in eyes with advanced retinoblastoma

  2014cites this paper
• Intra‐arterial chemotherapy for retinoblastoma. Challenges of a prospective study

  2014cites this paper
• Uveal Tumors: Diagnostic Techniques: Angiography

  2014cites this paper
• Effects of metformin on retinoblastoma growth in vitro and in vivo

  2014cites this paper
• Update on Ophthalmic Oncology 2012: Advances in Retinoblastoma and Uveal Melanoma

  2013cites this paper
• Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision

  2013cites this paper
• Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy

  2013cites this paper
• Successful treatment of macular retinoblastoma with superselective ophthalmic artery infusion of melphalan.

  2013cites this paper
• Central retinal artery occlusion in a 13-year-old child as a presenting sign of hyperhomocysteinemia together with high lipoprotein(a) level.

  2013cites this paper
• Combined chemotherapy and intra-arterial chemotherapy of retinoblastoma

  2013cites this paper
• Intravenous and intra-arterial chemotherapy for retinoblastoma: what have we learned?

  2012cites this paper
• Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma.

  2012cites this paper
• Validating a nonhuman primate model of super-selective intraophthalmic artery chemotherapy: comparing ophthalmic artery diameters.

  2012cites this paper
• Needs to Know Retinoblastoma: What the Neuroradiologist

  year unknowncites this paper